Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy-Reference-Cited by-同舟云学术

Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy

Published:2004-09 Issue:9 Volume:22 Page:1805-1811
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:Journal of Hypertension

Author:

Ibsen Hans,Wachtell Kristian,Olsen Michael H,Borch-Johnsen Knut,Lindholm Lars H,Mogensen Carl Erik,Dahl??f Bj??rn,Devereux Richard B,de Faire Ulf,Fyhrquist Frej,Julius Stevo,Kjeldsen Sverre E,Lederballe-Pedersen Ole,Nieminen Markku S,Omvik Per,Oparil Suzanne,Wan Ying

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference19 articles.

1. Microalbuminuria in essential hypertension: redefining the threshold

2. Arterial Hypertension, Microalbuminuria, and Risk of Ischemic Heart Disease

3. Prevalence of Microalbuminuria in a Large Population of Patients with Mild to Moderate Essential Hypertension

4. Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study

5. Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sonographic Optic Nerve Diameter and Clinical Biomarkers in Patients With Poorly Controlled Diabetes: A Comparative Analysis With Nondiabetic Subjects;Journal of Diagnostic Medical Sonography;2021-09-25

2. Association of Cardiovascular Disease with Micro Albuminuria in Type 2 Diabetes Mellitus;Pakistan Journal of Medical and Health Sciences;2021-05-30

3. Why albuminuria should be assessed more frequently in everyday clinical practice? Position statement;Polish Archives of Internal Medicine;2021-03-15

4. The Blockade of TACE-Dependent EGF Receptor Activation by Losartan-Erlotinib Combination Attenuates Renal Fibrosis Formation in 5/6-Nephrectomized Rats Under Vitamin D Deficiency;Frontiers in Medicine;2021-01-05

5. Hypertension and Diabetes;Endocrinology;2020